购物车
全部删除
您的购物车当前为空
别名 Lucentis
Anti-Ranibizumab Antibody (9W13) 是一种 Mouse 抗体,靶向 Ranibizumab。Anti-Ranibizumab Antibody (9W13) 可用于 ELISA。
Anti-Ranibizumab Antibody (9W13) 是一种 Mouse 抗体,靶向 Ranibizumab。Anti-Ranibizumab Antibody (9W13) 可用于 ELISA。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 40 μg | ¥ 3,218 | 5日内发货 |
| 产品描述 | Anti-Ranibizumab Antibody (9W13) is a Mouse antibody targeting Ranibizumab. Anti-Ranibizumab Antibody (9W13) can be used in ELISA. |
| 别名 | Lucentis |
| Ig Type | IgG1,κ |
| 克隆号 | 9W13 |
| 特异性 | The product is specific for Ranibizumab. The antibody is recommended as a detection antibody in a pharmacokinetic (PK) bridging assay with capture antibody Anti-Ranibizumab Antibody (5Q129) (TMAS-00091). |
| 应用 | ELISA |
| 推荐剂量 | ELISA: 0.01-0.1 µg/ml |
| 抗体种类 | Monoclonal |
| 宿主来源 | Mouse |
| 纯化方式 | Protein A affinity column |
| 性状 | Lyophilized. Reconstitute the lyophilized powder with deionized water (or equivalent) to a final concentration of 0.5 mg/ml. |
| 缓冲液 | Lyophilized with PBS, pH 7.4, containing 0.02% sodium azide. |
| 研究背景 | Ranibizumab with trade name Lucentis, is an FDA-approved drug for the treatment of patients with neovascular (Wet) age-related macular degeneration (AMD) and macular edema following retinal vein occlusion (RVO). It is a recombinant humanized IgG1 kappa isotype monoclonal antibody fragment. Ranibizumab binds to vascular endothelial growth factor A (VEGF-A) and blocks its activity. |
| 偶联 | Unconjugated |
| 免疫原 | Ranibizumab |
| 储存方式 | The lyophilized product store at -20°C or -80°C for 12 months. The reconstituted antibody can be stored at 2°C-8°C for 2-3 weeks or at -20°C for 12 months. Avoid repeated freeze-thaw cycles. |
| 运输方式 | Shipping with blue ice. |
| 存储 | -20°C for 1 year |